Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer
About this study
The purpose of this study is to find out how cancer treatments (chemotherapy and/or radiation therapy) affect reproductive and sexual health in people with early onset colorectal cancer. The study researchers will observe and track changes in hormone levels and in sexual and reproductive health in people with early onset colorectal cancer. This information will help researchers know more about how cancer treatments affect reproductive and sexual health, including the ability to have children (fertility).
- Condition
- Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma
- Tested
- Hormone biomarker analysis, QoL Questionnaires
- Sponsor
- Memorial Sloan Kettering Cancer Center
Who can join
- Age
- 18 to 50 years
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 9
- Minimum age: 18 years
- Maximum age: 50 years
- Study condition: Colorectal Cancer, Colorectal Neoplasms, Colorectal Carcinoma
- 18-40 years of age and premenopausal (female) or 18-50 years of age (male) at time of diagnosis
- Histologic diagnosis of colorectal adenocarcinoma
- Able and willing to participate in the informed consent process
- Eligible for curative adjuvant or neoadjuvant therapy for colon or rectal cancer
- Willing and able to complete protocol questionnaires
- Rectal patients only: Individuals who will be receiving chemotherapy, followed by chemoradiotherapy (ChemoRT)
Exclusion 4
- Prior systemic treatment for this malignancy
- Active or prior secondary malignancy
- History of ovarian resection (if female)
- Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception until the termination of gestation, confirmed by a positive hCG laboratory test.
Where
7 sites, 7 recruiting
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Cancer Center at Suffolk - Commack
Commack, New York, United States
Memorial Sloan Kettering Westchester
Harrison, New York, United States
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
and 1 more site on ClinicalTrials.gov
Contact
-
Andrea Cercek, MD
646-888-4189 cerceka@mskcc.org
-
Paul Romesser, MD
646-888-2118 romessep@mskcc.org
Potential match only. Final eligibility is determined by the study team.